Tetratricopeptide Repeat Domain 35 (TTC35) (Middle Region) Peptide
TTC35
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all TTC35 products
- TTC35 (Tetratricopeptide Repeat Domain 35 (TTC35))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-TTC35 antibody (Catalog #: ARP48331_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TTC35 (Tetratricopeptide Repeat Domain 35 (TTC35))
- Background
-
The exact function of TTC35 remains unknown.
Alias Symbols: KIAA0103, TTC35
Protein Interaction Partner: COX4NB,FAM158A,COX4NB,FAM158A
Protein Size: 297 - Molecular Weight
- 35 kDa
- Gene ID
- 9694
- NCBI Accession
- NM_014673, NP_055488
- UniProt
- Q15006
-
You are here:
